Skip to main content
Equibles
ABOS logo

ABOS · Acumen Pharmaceuticals, Inc. · Suppliers & Customers

Track ABOS — free

Use ABOS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABOS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.21 0.00 (-1.83%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Oct 26, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on our current operating plan, we believe there is substantial doubt about our ability to continue as a going concern for at least 12 months following the date of issuance of our unaudited condensed financial statements included in this Quarterly Report on Form 10-Q.”
View the 10-Q filed Oct 26, 2026
Market Cap
$15.48M
Shares
72.33M
Volume · Nov 13 2.78M Avg daily vol (3M) 2.53M

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones ABOS names, and the companies that name ABOS.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who ABOS sells to, buys from, competes and partners with

  • 1 supplier
  • 0 customers
  • 30 competitors
  • 2 partners

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1576885 CUSIP 00509G209 13F (30d) 77 filings 65 filers Visit website Investor relations